Pipeline
Nicox reports positive pre-NDA FDA meeting for IOP-lowering drop
NO-donating bimatoprost formulation remains on track for a summer 2026 new drug application submission.
Pipeline
FDA clears Cloudbreak Pharma's IND for phase 2 presbyopia drop trials
Clearance green lights advancement of CBT-199, an ophthalmic emulsion with a proprietary, water-free formulation and parasympathomimetic miotic agent.
Products
FDA approves DifGen's fluorometholone 0.1% complex generic for ocular inflammation
Prescription-based corticosteroid suspension is the second generic of AbbVie’s FML 0.1% to receive regulatory approval.
Research
Could RAR determine cataract risk?
Cost-effective biomarker emerges as potential tool for risk assessment and early prevention in cataract patients.
Research
Dual GIP-GLP-1 RA shows superior efficacy in lowering POAG, OHT risk
Tirzepatide consistently reduced the risk of glaucomatous disease compared to GLP-1 RAs, even among high-risk patients.
Legal
Samsung Biopeis and Regeneron settle EYLEA biosimilar US patent dispute
Settlement and license agreement clears the way for a January 2027 commercial launch of OPUVIZ 2 mg (aflibercept-yszy) injection.
Pipeline
Pandorum Tech raises $18M to expand operations for bioengineered cornea
Financing to advance biotech’s ‘liquid-based cornea’ Kuragenx, an eye drop bioengineered to revert an ulcerative cornea to its healthy state in less than 1 year.
Business
Arctic Vision acquires MDCO Technology's ophthalmic device business
Integration will support global ophthalmic pipeline expansion addressing significant unmet needs in retinal disease, dry eye, and ocular neuroprotection.
Research
Iron overload may increase glaucoma risk
Study proposes that systemic iron dysregulation is a modifiable risk factor for glaucomatous disease.
Business
VIEW Optometry launches to support independent practices
Doctor-founded alliance allows private practice optometrists to maintain ownership while benefiting from a network of tools and resources.
Pipeline
4DMT completes enrollment for phase 3 wet AMD gene therapy trial
4FRONT-1 study is evaluating 4D-150 as a single, low-dose IVT injection among treatment-naïve wet AMD patients; topline data expected in H1 2027.
Research
Seasonal variations play major role in CSC development
Observed increased incidence of CSC in spring and autumn provide potential insights into the disease’s pathogenesis.
Products
BVI reports first US implantations of FINEVISION HP Trifocal IOL
Surgeon-led rollout includes five successful procedures across the country of the FDA-approved, presbyopia-correcting lens.
Research
HOYA reports 6-month data on MiYOSMART iQ spectacle lenses for pediatric myopia
Interim results find advanced lens and D.I.M.S. triple enhanced design tech to be twice as effective in controlling axial elongation and disease progression.
Business
Leadership watch: Staar Surgical names co-CEOs, ACET adds to Board
Leadership changes are underway in the eyecare space—and we’ve got the latest.
Business
American College of Eye Technicians offers fast-track training program
Nonprofit’s 8-week, online program aims to address national staffing shortage of ophthalmic technicians with a new class of entry-level professionals.
Products
AEYE Health broadens Epic EMR integration for AI eye screening
Expanded deployment enables HCPs to order AEYE-DS’s portable, 1-minute diabetic retinopathy screenings without clinical workflow disruptions.
Research
Reducing chronic inflammation minimizes AMD-linked vision loss
Mouse model demonstrates role of NLRP3 in AMD pathology and highlights potential therapeutic approaches.
Business
AMETEK purchases LKC Technologies
Strategic acquisition includes the RETeval, an FDA-cleared, first-ever handheld ERG/VEP device for retina and optic nerve diseases.
Products